NexGel, Inc. is provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. The Company is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. It is specialized in custom gels by capitalizing on proprietary manufacturing technologies. The products it sells under its MedaGel brand primarily relate to over-the-counter (OTC) remedy solutions, such as blister and pain applications; while the products it sells under its LumaGel Beauty brand primarily relate to beauty and cosmetic solutions, such as wrinkle and skin cream applications.
Company Website: https://nexgel.com